Clinical Trial: Validation of a Predictive Score of Acute Chest Syndrome

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Validation of a Predictive Score of Acute Chest Syndrome

Brief Summary:

Vaso-Occlusive Crisis (VOC), the most common manifestation of sickle cell disease (SCD), is the first cause of death, particularly when complicated by an acute chest syndrome (ACS).

The PRESEV score could help the physicians to better manage VOC and could be used for future therapeutic trials. This predictive score of secondary ACS has to be validated in a multicenter international study.